4006-776-356 出国就医服务电话

免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / Optical Coherence Tomography and Optic Neuritis Not Related to Multiple Sclerosis (OCTON2)

Optical Coherence Tomography and Optic Neuritis Not Related to Multiple Sclerosis (OCTON2)

Study Description
Brief Summary:

The visual prognosis of optic neuritis not related to multiple sclerosis is unknown, both in terms of functional recovery and evolution.

This prospective cohort study aim to assess the ophthalmological evolution of patients presenting an episode of optic neuritis (NO) not related to a multiple sclerosis or to a clinically isolated syndrome.


Condition or disease
Optic Neuritis

Study Design
Layout table for study information
Study Type : Observational
Estimated Enrollment : 60 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation and Follow-up of Optic Neuritis Not Related to Multiple Sclerosis
Actual Study Start Date : September 14, 2020
Estimated Primary Completion Date : September 14, 2024
Estimated Study Completion Date : September 14, 2024
Arms and Interventions
Outcome Measures
Primary Outcome Measures :
  1. Visual acuity (ETDRS scale) [ Time Frame: 1 year ]
    Evolution over 1 year of the ophthalmological parameters of patients treated for an episode of optic neuritis not related to multiple sclerosis or a clinically isolated syndrome

  2. Thickness of the layers of the retina with Optical Coherent Tomography(OCT), [ Time Frame: 1 year ]
  3. Standard Humphrey Visual Field Test [ Time Frame: 1 year ]

Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients seen at the Adolphe de Rothschild Foundation for the first onset of an optic neuritis not related to multiple sclerosis and clinically isolated syndrome
Criteria

Inclusion Criteria:

  • First onset of an optic neuritis lasting for less than 1 month
  • With a brain MRI that does not meet the MS criteria

Exclusion Criteria:

  • Contra-indication to MRI
  • Pregnant or lactating woman
  • History of known ipsilateral optic neuritis
  • Ophthalmologic comorbidity in the ipsilateral eye that may interfere with the interpretation of the examinations
Contacts and Locations

Contacts
Layout table for location contacts
Contact: Laurence SALOMON, MD PhD +33 1 48 03 64 31 lsalomon@for.paris
Contact: Amélie YAVCHITZ, MD +33 1 48 03 64 54 ayavchitz@for.paris

Locations
Layout table for location information
France
Fondation A. de Rothschild Recruiting
Paris, France, 75019
Contact: Romain DESCHAMPS, MD       rdeschamps@for.paris   
Principal Investigator: Romain DESCHAMPS         
Sponsors and Collaborators
Fondation Ophtalmologique Adolphe de Rothschild
Investigators
Layout table for investigator information
Principal Investigator: Romain DESCHAMPS, MD Fondation A. de Rothschild
Tracking Information
First Submitted Date May 20, 2019
First Posted Date May 24, 2019
Last Update Posted Date September 16, 2020
Actual Study Start Date September 14, 2020
Estimated Primary Completion Date September 14, 2024   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: May 22, 2019)
  • Visual acuity (ETDRS scale) [ Time Frame: 1 year ]
    Evolution over 1 year of the ophthalmological parameters of patients treated for an episode of optic neuritis not related to multiple sclerosis or a clinically isolated syndrome
  • Thickness of the layers of the retina with Optical Coherent Tomography(OCT), [ Time Frame: 1 year ]
  • Standard Humphrey Visual Field Test [ Time Frame: 1 year ]
Original Primary Outcome Measures Same as current
Change History
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Optical Coherence Tomography and Optic Neuritis Not Related to Multiple Sclerosis
Official Title Evaluation and Follow-up of Optic Neuritis Not Related to Multiple Sclerosis
Brief Summary

The visual prognosis of optic neuritis not related to multiple sclerosis is unknown, both in terms of functional recovery and evolution.

This prospective cohort study aim to assess the ophthalmological evolution of patients presenting an episode of optic neuritis (NO) not related to a multiple sclerosis or to a clinically isolated syndrome.

Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Patients seen at the Adolphe de Rothschild Foundation for the first onset of an optic neuritis not related to multiple sclerosis and clinically isolated syndrome
Condition Optic Neuritis
Intervention Not Provided
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Recruiting
Estimated Enrollment
 (submitted: May 22, 2019)
60
Original Estimated Enrollment Same as current
Estimated Study Completion Date September 14, 2024
Estimated Primary Completion Date September 14, 2024   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • First onset of an optic neuritis lasting for less than 1 month
  • With a brain MRI that does not meet the MS criteria

Exclusion Criteria:

  • Contra-indication to MRI
  • Pregnant or lactating woman
  • History of known ipsilateral optic neuritis
  • Ophthalmologic comorbidity in the ipsilateral eye that may interfere with the interpretation of the examinations
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts
Contact: Laurence SALOMON, MD PhD +33 1 48 03 64 31 lsalomon@for.paris
Contact: Amélie YAVCHITZ, MD +33 1 48 03 64 54 ayavchitz@for.paris
Listed Location Countries France
Removed Location Countries  
 
Administrative Information
NCT Number NCT03963310
Other Study ID Numbers RDS_2019_8
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement Not Provided
Responsible Party Fondation Ophtalmologique Adolphe de Rothschild
Study Sponsor Fondation Ophtalmologique Adolphe de Rothschild
Collaborators Not Provided
Investigators
Principal Investigator: Romain DESCHAMPS, MD Fondation A. de Rothschild
PRS Account Fondation Ophtalmologique Adolphe de Rothschild
Verification Date September 2020